Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

MedMira Inc > waiting for promised JANUARY UPDATES
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by august202013on Jan 29, 2023 9:50pm
200 Views
Post# 35253239

RE:RE:waiting for promised JANUARY UPDATES

RE:RE:waiting for promised JANUARY UPDATES FASTEN YOUR SEAT BEALT MRMARKET1 & PETEY78 MEDMIRA GOING FOR A RIDE NEXT WEEK,

WITHOUT NEWS TOMORROW IT SHOULD OPEN HIGHER BUT WITH NEWS DEPENDING ON MRMARKET1 WHICH NUMBER MIGHT EVEN TAKE IT EVEN HIGHER. SCOTTY PROBABLY GOING TO SAY THE SAME.

NO ASTRONOMICAL SALES BUT WITH MORE CONFIDENCE AMONGS ITS SHAREHOLDERS WILL PLACE SOME SELLING RESTRAINS AND AS MENTIONED TIGHT LIQUIDITY EVEN THOUGH BIG OUTSTANDING SHARES SIMPLY BECAUSE SHAREHOLDERS WON'T WANT TO MISS THE BOAT. 

EVIDENCE THROUGH LOW VOLUME RECENT TRADING PERIODS. OFF COURSE SOME WANT TO  TAKE PROFIT BUT THOSE SAME SHAREHOLDERS WILL BE BACK AT HIGHER PRICE LATER. SO DO THE MATH WHICH IS THE BETTER APPROACH.

ANYWAY SIT BACK AND RELAX TOMORROW AND PROBABLY TAKE ONE WEEK LEAVE WITH OPTION FOR EXTENDED LEAVE AND ENJOY ! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities